Evaluation of the Effect of Changyou Probiotic Flavored Yogurt on Intestinal Health

NCT ID: NCT04375475

Last Updated: 2020-05-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

198 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-02-25

Study Completion Date

2019-04-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This was a randomized, double-blind, single-center, placebo-controlled, three-arm study.

The objectives of this study were to evaluate the effect of the Bright Changyou Probiotic Flavored Yogurt on:

Improving gastrointestinal health; Relieving symptoms of functional constipation or functional diarrhea; Improving gut immunity; Adjusting microbiological flora in gastrointestinal tract.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Intestinal Health

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Bright Changyou probiotic flavored yogurt

Bright Changyou probiotic flavored yogurt contains 5.0×10\^8cfu/g of probiotics including Lactobacillus bulgaricus, Streptococcus thermophilus, Bifidobacterium lactis, Lactobacillus acidophilus, Lactobacillus plantarum ST-Ⅲ (7mg/kg), and 1.5% of inulin

Group Type EXPERIMENTAL

Bright Changyou probiotic flavored yogurt

Intervention Type DIETARY_SUPPLEMENT

Oral consumption of Bright Changyou probiotic flavored yogurt 100 g at a time and twice per day for 28 days. The experimental product has similar package and taste as the comparators.

Bright Changyou lactobacillus flavored yogurt

Bright Changyou flavored yogurt contains probiotics including Lactobacillus bulgaricus, Streptococcus thermophilus, Bifidobacterium lactis, Lactobacillus acidophilus, and Lactobacillus plantarum ST-Ⅲ (7mg/kg)

Group Type ACTIVE_COMPARATOR

Bright Changyou lactobacillus flavored yogurt

Intervention Type DIETARY_SUPPLEMENT

Oral consumption of Bright Changyou lactobacillus flavored yogurt 100 g at a time and twice per day for 28 days.

Bright flavored yogurt

Bright flavored yogurt contains Lactobacillus bulgaricus, Streptococcus thermophilus, Lactobacillus acidophilus, Bifidobacterium lactis, and Lactobacillus casei LC2W (0.1 mg/kg)

Group Type ACTIVE_COMPARATOR

Bright flavored yogurt

Intervention Type DIETARY_SUPPLEMENT

Oral consumption of Bright flavored yogurt 100 g at a time and twice per day for 28 days.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Bright Changyou probiotic flavored yogurt

Oral consumption of Bright Changyou probiotic flavored yogurt 100 g at a time and twice per day for 28 days. The experimental product has similar package and taste as the comparators.

Intervention Type DIETARY_SUPPLEMENT

Bright Changyou lactobacillus flavored yogurt

Oral consumption of Bright Changyou lactobacillus flavored yogurt 100 g at a time and twice per day for 28 days.

Intervention Type DIETARY_SUPPLEMENT

Bright flavored yogurt

Oral consumption of Bright flavored yogurt 100 g at a time and twice per day for 28 days.

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Men or women aged 25-45 years old;
* Functional constipation or diarrhea diagnosed by Rome III criteria;
* Agree not to take any dietary supplements or dairy products other than the study products during the study period;
* Agree not to take any supplements or dairy products containing prebiotics/probiotics other than the study products during the study period;
* Agree not to participant in other interventional studies during the study period;
* Fully understand the property, purpose, benefits and potential risk and side effect from the study;
* Agree to follow all study requirements and procedures;
* Signed informed consent.

Exclusion Criteria

* Currently receiving treatment for gastrointestinal symptoms;
* Lactose intolerance;
* Having diseases or conditions that may affect intestinal function, such as history of gastrointestinal resection, colon or rectal cancer, inflammatory bowel disease, diabetes, hyperthyroidism or hypothyroidism, Hirschsprung's disease, scleroderma, or Anorexia nervosa;
* Currently under diet control or in use of medicine or supplements for weight control or that might affect appetite;
* Have had laxatives or other substance that will enhance digestion within two weeks before the study begins;
* Have had dairy products or other food containing probiotics within 10 days before the study begins;
* Currently having diarrhea;
* Currently pregnant or breast-feeding, or plan to be pregnant during the study period;
* Not be able to follow study procedures according to investigators evaluation.
Minimum Eligible Age

25 Years

Maximum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Bright Dairy & Food Co., Ltd

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Shanghai Jiaoton University Affiliated Xinhua Hospital

Shanghai, , China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

19-SM-02-GM-001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Yogurt and GI Health
NCT05931471 COMPLETED NA
Probiotics to Promote Intestinal Health
NCT02046512 COMPLETED PHASE4